Hoover v. Eckerd's Cut Rate Medicine Co., 696.
Decision Date | 21 October 1931 |
Docket Number | No. 696.,696. |
Parties | HOOVER et al. v. ECKERD'S CUT RATE MEDICINE CO., Inc. |
Court | U.S. District Court — District of Delaware |
Charles F. Curley, of Wilmington, Del., and Clifford E. Dunn and David A. Woodcock, both of New York City, for plaintiffs.
Robert Starr Allyn, of New York City, and Henry R. Isaacs, of Wilmington, Del., for defendant.
This is a suit in equity brought by Fred R. Hoover, as owner of the legal title to United States letters patent Nos. 1,222,144, and 1,225,362, granted to William M. Ruthrauff April 10, 1917, and May 8, 1917, respectively, upon applications filed October 2, 1916, against Eckerd's Cut Rate Medicine Company, Inc. Each patent is for a dentifrice. Pursuant to stipulation between the parties, an order was entered making W. M. Ruthrauff Company, a party plaintiff. It is the manufacturer and licensee under these patents of a tooth paste sold under the trade-name of "Acident." The bill contains the usual prayers for an injunction and an accounting of profits and damages.
The defendant attacks plaintiffs' title, contends that there is no patentable invention involved in either patent, that the patenteee abandoned any invention which he might have had, and that, even if the patents are valid, defendant has not infringed either of them.
The principal constituent of the enamel of the teeth is tricalcium or tribasic calcium phosphate. It is soluble in hydrochloric, acetic, or lactic acid in the sense that it will combine with them to form monobasic and dibasic calcium phosphate, both of which are soluble calcium salts, acid in character. Monobasic and dibasic calcium phosphates, when neutralized by an alkali, precipitate tribasic calcium phosphate.
There is evidence that nature hardens teeth through the action of saliva, and that calcium salts are abstracted from the blood stream and secreted by the three glands of the mouth into the saliva. Saliva is sometimes alkaline and sometimes acid; the change occurring several times a day.
It was the aim and object of the patentee to calcify the teeth by imitating or supplementing what he assumed to be nature's process.
Patent No. 1,222,144, the first in suit, relates particularly to an acid calcifying dentifrice. It contains seven claims, of which claims 1 and 2 are in issue. They read:
The second patent in suit, No. 1,225,362, like the first, relates to an acid calcifying dentifrice. Both patents were applied for on the same day. The second patent contains five claims, all of which are in suit. It is sufficient to quote claim 1, which reads:
The plaintiffs contend that the essence of the invention of the two patents in suit it to provide a tooth paste that will calcify the teeth; the "gist of the invention is to provide a calcifying dentifrice."
There is some scientific opinion in support of the theory that the enamel of the teeth is porous. It is admitted, however, that the spaces, if spaces there be, are infinitesimally small and are close to the limit of visibility under the microscope. It is significant that plaintiffs' expert and the patentee entertain different theories as to the spaces or interstices in the teeth. The expert testified: "Here you have got little columns, rods, apparently there, with a little space in between the rods, as if you had a handful of lead pencils here and there is a little space in between, and I should say that the space, judging from the appearance of the microscope, seems to be pretty close to the limit of visibility, which is about 1/200th of a hair diameter." On the other hand, the patentee testified: It thus appears that the nature or...
To continue reading
Request your trial-
THE UNIVERSITY OF ILLINOIS FOUND. v. Block Drug Co.
...that he personally had not made lactic acid determinations in saliva. This is a different situation from Hoover, v. Eckerd's Cut Rate Medicine Co., Inc., D.C., 53 F.2d 215, 217, affirmed 3 Cir., 63 F.2d 813, 22 Defendants' Exhibit 4P, item 34, page 79. 23 Hubble v. United States, 179 U.S. 7......
-
Application of Langer
...environmental gases. We thus cannot consider in vitro tests alone to evidence actual utility. Compare * * * Hoover et al. v. Eckerd's Cut Rate Medical Medicine Co., Inc., 53 F.2d 215 D.Del.1931, affirmed 63 F.2d 813 3rd After considering appellant's petition for reconsideration, the board r......